"Contakt World: Truth in Health" Podcast Unveils Fourth Episode - Featuring In-Depth Interview with Executive for the National Association of County and City Health Officials Dr. E. Oscar Alleyne Entitled "The Epidemiology of Public Trust"

Tracker Ventures Corp. ("Tracker" or the "Company") (CSE:TKR)(OTC PINK:TLOOF) (FRA:B2I) is pleased to announce that Contakt LLC ("Contakt World"), a technology company modernizing public health and safety, has released the fourth episode of the "Contakt World: Truth in Health" podcast. The podcast is available on iHeartRadio and other popular streaming sites for podcasts

Listen Now Here

"This episode highlights racism and misformation as what they truly are - diseases that severely impact our country's public health system," said Justin Beck CEO of Contakt World and Host of the podcast. "We're honored to have Dr. Alleyne take us behind the front lines and discuss the problems health officials are facing and uncover equitable solutions through technology, innovation and communication."

A description of the fourth episode can be found below.

"Contakt World: Truth in Health" Podcast

Episode 4: The Epidemiology of Public Trust

"Did we not know that the big bug would hit? Or did we? Did our trusted officials just kick the can down the road? Or does the problem lie with the general public - and their unwillingness to listen to expert opinion and information? This week's episode of Contakt World dives into the hot button issues of race, misinformation systems, pandemic plans and the politics of public health - specifically, through the lens of Dr. E. Oscar Alleyne, epidemiologist and Chief of Programs and Services for NACCHO, the National Association of County and City Health Officials. Join our hosts Justin Beck, Catherine Delcin and Deepti Pahwa, as they speak with Alleyne, and discuss the challenges faced by public health agencies, epidemiologists and elected officials. As always, we'll talk about how to help our local health departments - and encourage innovation and technology integration - all while remaining empathetic with an eye toward health equity for all."

"Contakt World: Truth in Health" is distributed by the iHeartPodcast Network and also available on Apple and Spotify. For video previews, highlights and full-length episodes, please visit Contakt World on YouTube.

* No content within or related to the podcast referenced herein has been evaluated by the FDA. Any information presented by Contakt World or its guests is not intended to treat or cure any disease, and no claims are made as to the accuracy or sufficiency thereof.

Contakt World - Tracker Transaction

Tracker and Contakt World are parties to a definitive amalgamation agreement pursuant to which Tracker will indirectly acquire (the "Acquisition") a 100% interest in Contakt World. For further information respecting the Acquisition, please refer to the Company's news release dated December 8, 2020. Trading of Tracker's shares on the Canadian Securities Exchange (the "CSE") has been halted in connection with the announcement of the Acquisition and is not expected to resume until the CSE has approved a Form 2A Listing Statement for the resulting issuer from the Acquisition. There can be no assurance that the Acquisition will be completed on the terms proposed in the amalgamation agreement or at all.

About Contakt World

Contakt World is a technology and media company innovating public health agency connections with their community, with the goal of becoming the most trustworthy, accessible and scalable digital public health and safety platform globally - addressing the needs of a post-pandemic world. Contakt World combines aggressive research and development, human-centered design, next-gen data integrations, and strategic health partnerships to empower and build mutual trust within communities, contributing towards health equity for users around the world. Contakt World's first suite of tools emerge from the urgency surrounding coronavirus to manage the pandemic through innovative contact tracing and case management spanning multiple modes of communication. For more information, please visit the Company's website at www.contakt.world.

Tracker Ventures Contact
Geoff Balderson
CEO and Director
Direct: 604-602-0001

Media Contact
Kevin Harrington
Account Director - 5WPR
contakt@5wpr.com

Investor Contact
Lucas A. Zimmerman
Senior Vice President - MZ North America
Direct: 949-259-4987
contakt@mzgroup.us
www.mzgroup.us

The CSE has not reviewed, approved or disapproved the content of this news release.

Forward Looking Statements Disclaimer

This press release contains "forward-looking information" within the meaning of applicable securities laws ("forward-looking statements"), including, but not limited to, statements with respect to the future prospects of Tracker and Contakt World. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "projects", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or result expressed or implied by such forward-looking statements. Although forward-looking statements contained in this press release are based upon what management of Tracker and Contakt World believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include those risks listed above as well as additional risks like regulatory changes, general economic, market, political, or business conditions, actual or perceived implications of COVID-19 immunization or treatments and the timing and delivery thereof, meeting or maintaining various conditions of HIPAA, GDPR, and CCPA compliance, protection of the Company's and Contakt World's intellectual property, and adoption of the Contakt World platform or apps by government, B2B, B2I customers and consumer end-users. Tracker and Contakt World undertake no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements.

SOURCE: Tracker Ventures Corp.

View source version on accesswire.com:
https://www.accesswire.com/624958/Contakt-World-Truth-in-Health-Podcast-Unveils-Fourth-Episode-Featuring-In-Depth-Interview-with-Executive-for-the-National-Association-of-County-and-City-Health-Officials-NACCHO-Dr-E-Oscar-Alleyne-Entitled-The-Epidemiology-of-Public-Trust

News Provided by ACCESSWIRE via QuoteMedia

Tracker Ventures CSE:TKR Emerging Tech Investing

Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances

Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI OTCQX: NSCIF FRA: 1N1 ), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, announces that its subsidiary Nanalysis Corp. is receiving advisory services and up to $1.45 million in non-repayable, non-dilutive funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), to develop Artificial Intelligence based software tools to detect illicit substances on top of the Company's portable Nuclear Magnetic Resonance (NMR) spectrometers.

In the global fight against substance abuse, federal, state, provincial, county and municipal governments around the world are tasked with characterizing increasing volumes of seized contraband. This characterization requires an array of different analytical techniques and is carried out by skilled forensic scientists in thousands of laboratories worldwide. In many cases these laboratories face significant sample backlog due to volume and may have difficulties in identifying new designer drugs.

This project, scheduled for three years, will focus on using quantum mechanical modelling and AI tools to perform analysis of magnetic resonance results generated by Nanalysis benchtop instruments. These tools will not only identify known illicit drugs but will also identify unknown drugs that are derivatives of known illicit substances also referred to as designer drugs or new psychoactive substances (NPS). The non-destructive nature of NMR spectroscopy and the fact that unlike traditional forensic testing methods, it is non-targeted, uniquely positions it to help identify these drugs. The company is developing this application in the context of its quantitative NMR platform technology, which has other applications as well, beyond illicit drug detection.

"We are very grateful for the support of NRC IRAP to further develop complementary software for our Benchtop products," said Nanalysis CEO and Founder Sean Krakiwsky . "This project builds on our ongoing relationship with the LKA police organization in Germany and on our continued culture of magnetic resonance innovation. We look forward to providing more solutions for law enforcement in combatting the increasingly societal problem of designer drugs and other deadly toxins."

About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1)

Nanalysis Scientific Corp. operates two primary businesses: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz device, the most powerful and most advanced compact NMR device ever brought to market.

The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners. With its partners, the Company provides scientific equipment sales and maintenance services globally.

In 2022, through its subsidiary KPrime, the Company was awarded a five-year, $160 million contract with the Government of Canada to provide maintenance services for passenger screening equipment in Canadian airports. This has resulted in the expansion of the Company's Security Services business. The Company is providing airport security equipment maintenance services for the Government of Canada in each province and territory of Canada. In addition, the Company provides commercial security equipment installation and maintenance services to a variety of customers in North America .

Notice regarding Forward Looking Statements and Legal Disclaimer

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia: https://www.prnewswire.com/news-releases/nanalysis-corp-receives-funding-supporting-ai-software-development-for-detection-of-illicit-substances-302108047.html

SOURCE Nanalysis Scientific Corp.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/April2024/04/c4926.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Nextech3D.ai Releasing New 3D GPT-AI For Toggle3D.ai The "All-IN-ONE 3D Platform"

Launching Several Enhanced AI Productivity Tools

Content Management of 3D models (3D Cloud)
New EXPANDED Generative AI texturing library
AI 3D Mesh Search Engine
Join the CEO Livestreams TODAY April 4 showcasing NEW AI Technology

Nextech3D.ai (OTCQX:NEXCF)(CSE:NTAR)(FSE:EP2), a patented 2D-3D Generative AI-Powered 3D model supplier (Patent #11,948,248) for Amazon, Miele, P&G, Kohls, Wesfarmers Group ``Bunnings" (Australia's largest listed company) and other major e-commerce retailers is thrilled to integrate various AI capabilities from its technology stack into the Toggle platform boosting 3D modeling productivity. The Company's distinctive AI mesh search algorithm is now fully installed, enabling 3D modelers to search for quad 3D meshes using just a 2D image. The new and improved Toggle platform allows for the purchase of the 3D mesh a la carte and then the customization of the 3D model's texture. This AI powered streamlined process empowers users to embark on their 3D journey with only a 2D image, leveraging the user-friendly AI tools available in the Toggle platform. Additionally, this new AI mesh search engine with a la carte buying of 3D meshes allows Nextech3D.ai to create an extra revenue stream by monetizing its extensive 3D mesh library

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Aether Announces Late Filing of Annual Financial Statements and Management Cease Trade Order

(TheNewswire)

Vancouver, B.C. TheNewswire April 3, 2024 - Aether Global Innovations Corp. (CSE:AETH) (OTC:AETHF) (Frankfurt:4XA) (WKN#A2N8RH) ("Aether Global", "AETH", or the "Company"), announced today that, as a result of delays to its audit, the Company's annual financial statements and accompanying management's discussion and analysis for the fiscal year ended November 30, 2023 (the "Annual Filings") were not finalized by April 2, 2024, being the date that such filings are due under applicable Canadian securities law requirements. The Company has applied for, and has been granted, a management cease trade order (the "MCTO") by the British Columbia Securities Commission.

News Provided by TheNewsWire via QuoteMedia

Keep reading...Show less

NEO Battery Materials Announces Appointment of Dr. Dongmok Whang as New Director

T S X V : NBM ) ( OTC: NBMFF )

NEO Battery Materials Ltd. (" NEO " or the " C o mpan y "), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce the appointment of Dr. Dongmok Whang, NEO's Lead Scientific Advisor, as a new Director of the Company.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

PRINCIPAL TECHNOLOGIES ANNOUNCES LOAN FINANCING AND PRIVATE PLACEMENT AND PROVIDES UPDATE ON VIVOSTAT A/S ACQUISITION

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES /

Principal Technologies Inc. (the " Company ") (TSXV: PTEC) (FSE: J07), is pleased to announce that on March 8, 2024 it entered into a binding commitment letter with the effect that the GreenIslands Opportunities Fund (the " Lender ") will provide a secured loan in the principal amount of €8,000,000 (the " Loan ") to provide acquisition financing with respect to the cash portion of the purchase price for Vivostat AS (" Vivostat "), as further outlined in its news release dated February 6, 2024 and for general working capital purposes.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

"Contakt World: Truth in Health" Podcast Unveils Fourth Episode - Featuring In-Depth Interview with Executive for the National Association of County and City Health Officials Dr. E. Oscar Alleyne Entitled "The Epidemiology of Public Trust"

Latest News

Latest Press Releases

Related News

TOP STOCKS